GLP-1 analogues as a new treatment option for hypothalamic obesity in adults: report of nine cases
Tell every procedural clinician that you take a GLP-1 medication Current Wegovy labeling includes a warning about rare pulmonary aspiration during general anesthesia or deep sedation
These effectiveness complaints are significant because they raise questions about compounded medication quality
You can have an increase in hunger when you stop taking it, which could result in weight gain
Overall, the three well-defined clusters 1a, 2c, 2d comprise transcripts of the high, low and intermediary levels of expression, correspondingly
Older adults considering GLP-1 medications or medical weight loss should be monitored carefully and should prioritize strength, mobility, protein intake, and functional health not just scale weight